Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature

被引:89
作者
Belinchon, I. [1 ]
Rivera, R. [2 ]
Blanch, C. [3 ]
Comellas, M. [4 ]
Lizan, L. [4 ,5 ]
机构
[1] Hosp Gen Univ Alicante, Dept Dermatol, Alicante, Spain
[2] Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain
[3] Novartis Farmaceut SA, Barcelona, Spain
[4] Outcomes 10, Castellon de La Plana, Spain
[5] Univ Jaime I, Dept Med, Castellon de La Plana, Spain
关键词
psoriasis; patient preference; adherence; satisfaction; systematic review; patient-reported outcomes; European Union; CLINICAL-PRACTICE; BIOLOGIC THERAPY; EXPERIENCE; IMPROVEMENT; ETANERCEPT; SEVERITY; OUTCOMES; SAFETY; MEDICATION; ARTHRITIS;
D O I
10.2147/PPA.S117006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Adherence to treatment in patients with psoriasis is often poor. An investigation of patient preferences and satisfaction with treatment may be important, based on the expected correlation with therapy compliance. This paper aims to examine and describe the current literature on patient preferences, satisfaction and adherence to treatment for psoriasis in the European Union (EU). Methods: Electronic searches were conducted using PubMed, ISI Web of Knowledge, Scopus, Spanish databases and Google Scholar. European studies published in English or Spanish between January 1, 2009 and December 31, 2014 regarding patient-reported outcomes in psoriatic patients were included. Studies conducted in non-EU countries, letters to the editor, editorials, experts' opinions, case studies, congress proceedings, publications that did not differentiate between patients with psoriasis and psoriatic arthritis or studies related to specific treatment were excluded. Results: A total of 1,769 titles were identified, of which 1,636 were excluded as they were duplicates or did not provide any relevant information. After a full-text reading and application of the inclusion/exclusion criteria, 46 publications were included. This paper will describe publications on adherence (n=4), preferences (n=5) and satisfaction with treatment (n=7). Results related to health-related quality of life articles (n=30) have been published elsewhere. Adherence rates are generally low in psoriasis patients regardless of the type of treatment, severity of disease or methods used to measure adherence. Biologic therapy is associated with greater clinical improvement. There is a direct association between physician recommendations, patient preferences and several domains of treatment satisfaction. Conclusion: The results of this review support the conclusion that adherence rates in patients with psoriasis are suboptimal and highlight the need to improve patient compliance and satisfaction with treatment. Patients' preferences should be taken into account in the treatment decision-making process in order to improve patients' clinical outcomes by ensuring satisfaction and adherence.
引用
收藏
页码:2357 / 2367
页数:11
相关论文
共 51 条
[1]   Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre [J].
Antoniou, C. ;
Stefanaki, I. ;
Stratigos, A. ;
Moustou, E. ;
Vergou, T. ;
Stavropoulos, P. ;
Avgerinou, G. ;
Rigopoulos, D. ;
Katsambas, A. D. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (05) :1117-1123
[2]   Adherence in the Treatment of Psoriasis: A Systematic Review [J].
Augustin, M. ;
Holland, B. ;
Dartsch, D. ;
Langenbruch, A. ;
Radtke, M. A. .
DERMATOLOGY, 2011, 222 (04) :363-374
[3]  
Barton JL, 2009, PATIENT PREFER ADHER, V3, P335
[4]   Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice [J].
Berends, Maartje A. M. ;
Driessen, Rieke J. B. ;
Langewouters, Annechien M. G. ;
Boezeman, Jan B. ;
Van de Kerkhof, Peter C. M. ;
De Jong, Elke M. G. J. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (02) :76-83
[5]   Maximizing patient adherence for optimal outcomes in psoriasis [J].
Bewley, A. ;
Page, B. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 :9-14
[6]   Quality of life in patients with psoriasis [J].
Bhosle, Monali J. ;
Kulkarni, Amit ;
Feldman, Steven R. ;
Balkrishnan, Rajesh .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[7]   Tolerability and Safety of Biological Therapies for Psoriasis in Daily Clinical Practice: A Study of 103 Italian Patients [J].
Brunasso, Alexandra Maria Giovanna ;
Puntoni, Matteo ;
Salvini, Camilla ;
Delfino, Chiara ;
Curcic, Pero ;
Gulia, Andrea ;
Massone, Cesare .
ACTA DERMATO-VENEREOLOGICA, 2011, 91 (01) :44-49
[8]   Better medication adherence results in greater improvement in severity of psoriasis [J].
Carroll, CL ;
Feldman, SR ;
Camacho, FT ;
Balkrishnan, R .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (04) :895-897
[9]   Assessing Psoriasis Severity and Outcomes for Clinical Trials and Routine Clinical Practice [J].
Chalmers, Robert J. G. .
DERMATOLOGIC CLINICS, 2015, 33 (01) :57-+
[10]   Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study [J].
Christophers, Enno ;
Segaert, Siegfried ;
Milligan, Gary ;
Molta, Charles T. ;
Boggs, Robert .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (03) :193-198